This Biotech 60%. Healthcare Stocks See Fresh $11M Bet
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Determining which grocery store credit card is best for cash back requires comparing benefits. Find the right card to boost your rewards.
26,359 articlesA top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
June can be a pivotal month for Carnival stock. This guide breaks down three compelling reasons to consider buying in...
Two pharma giants sit at the center of the booming weight-loss drug market. This piece breaks down which could offer ...
When a fund trims large holdings, it can signal shifting risk and opportunity. This article explains why an investmen...
Hims & Hers announces a billion-dollar cross-border deal to expand telehealth and wellness services, signaling a bold...
Oil clears $100 a barrel, sending Exxon and Chevron higher in after-hours trading while Berkshire Hathaway retreats a...
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Volatile markets test an investor’s nerves and resolve. The key to thriving, not just surviving, is focusing on a dis...
Roadrunner, the AI-powered CPQ startup, today disclosed a $27 million funding round led by Kleiner Perkins and FOUNDE...
Anthropic stunned markets with a Series H that values the private AI firm near $1 trillion, signaling a new era for p...
Oklo faces a pivotal moment after July. This piece explains a single catalyst investors should watch, the potential s...
A blockbuster film about risk and wonder offers more than entertainment. This piece translates Steven Spielberg’s Jur...